CORIANNE VANDERKOLK: Open Payments
NPI 1104267806 · LINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 70 payments from 16 companies in 2025. Trend: 2023 $866 · 2024 $1,124 · 2025 $1,163
Food & beverage: $1,160Education: $2
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $212 |
| Novo Nordisk Inc | 12 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $188 |
| Vanda Pharmaceuticals Inc. | 10 | $175 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Lilly USA, LLC | 3 | $52 |
| ABIOMED | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Tris Pharma Inc | 2 | $29 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Jornay PM, QULIPTA, Auvelity, Ozempic, Rybelsus.
Industry payments across IN — which companies pay providers there.
